Celldex Therapeutics Inc
NASDAQ:CLDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
P
|
Paccar Inc
SWB:PAE
|
US |
|
Camtek Ltd
NASDAQ:CAMT
|
IL |
|
S
|
Semirara Mining and Power Corporation
XPHS:SCC
|
PH |
|
LG Electronics Inc
F:LGLG
|
KR |
|
Infosys Ltd
NSE:INFY
|
IN |
|
Pultegroup Inc
NYSE:PHM
|
US |
|
Sun Hung Kai Properties Ltd
HKEX:16
|
HK |
|
P
|
PennantPark Floating Rate Capital Ltd
TASE:PFLT
|
US |
|
Pebble Group PLC
LSE:PEBB
|
UK |
|
P
|
PetroChina Co Ltd
F:PC6
|
CN |
|
A
|
ams-OSRAM AG
VSE:AMS2
|
AT |
|
L
|
Link Real Estate Investment Trust
SWB:L5R
|
HK |
|
A
|
Aurubis AG
DUS:NDA
|
DE |
|
Levi Strauss & Co
NYSE:LEVI
|
US |
|
D
|
DaVita Inc
DUS:TRL
|
US |
|
Chunghwa Telecom Co Ltd
TWSE:2412
|
TW |
|
S
|
Sonic Automotive Inc
SWB:SA8A
|
US |
|
S
|
Sasol Ltd
DUS:SAOA
|
ZA |
|
Geberit AG
SIX:GEBN
|
CH |
|
S
|
Seagate Technology Holdings PLC
XBER:847
|
SG |
|
Aedifica NV
F:AOO
|
BE |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
2.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
